Should The U.S. Government Buy A Drug Company To Save Money?
Most of the millions in the U.S. who are infected with hepatitis C can't afford the cure. Some say the U.S. could save money and cure more people if it bought the drugmaker Gilead Sciences Inc.
Read more on NPR
Health & Science - March 18, 2017 at 02:49AM - Should The U.S. Government Buy A Drug Company To Save Money?
Không có nhận xét nào:
Đăng nhận xét